ACE2 and COVID-19: This, on the one hand, is consistent with the epidemiological evidence that females are less likely to develop severe COVID-19 than males73 and, on the other hand, provides additional support on the role of ACE2 internalization in protecting cells from SARS-CoV-2 infection.